NCT06091475View on ClinicalTrials.gov

Therapy to Maintain Remission in Dilated Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 2, 2023

Primary Completion Date

August 15, 2026

Study Completion Date

September 15, 2026

Conditions
Heart FailureCardiomyopathy, DilatedCardiomyopathiesHeart Diseases
Interventions
DRUG

Other

Withdrawal of mineralocorticoid receptor antagonists and/or sodium glucose cotransporter 2 inhibitors

Trial Locations (1)

Unknown

RECRUITING

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Imperial College London

OTHER